...
首页> 外文期刊>Studia Universitatis Vasile Goldis: Seria Stiintele Vietii >Comparative therapeutical study at the patients with polychistic ovars
【24h】

Comparative therapeutical study at the patients with polychistic ovars

机译:多发性卵巢癌的比较治疗研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The objective. The purpose of this study is the comparison of the clinical effects gained as the result of the administration of an analogues of gonadorelin - triptorelin at the patients that have been diagnosed with the syndrome of polychistic ovary (SOP), against the administration of an oral combined contraceptive - Diane 35. Material and method. The study included a number of 24 patients, with the average age of 23,2 that were diagnosed with SOP. The patients were divided aleatory into 2 groups: group A, formed by 12 women (50%) used Diane 35, and group B, 12 patients (50%), used Diphereline 3,75. Results. The introduction of Diphereline therapy 3,75 in injectable administration improved the clinic symptoms (acne, hirsutism, amenorrhea, the morphology of ovaries). The results of the study show the therapeutically efficiency of the preparate Diane 35 on the symptoms of androgen nature - especially acne. Conclusions. The utilisation of preparate Diphereline 3,75 at the patients that have been diagnosed with SOP represents the most efficient therapeutically variant, aspect that had been proved by clinical, hormonal and morphological data. Additionally this formula permits the maintenance of the obtained results on a long time.
机译:目标。这项研究的目的是比较经确诊为多发性卵巢综合征(SOP)的患者服用促性腺激素-雷公藤瑞林类似物与口服联合用药相比较的临床效果避孕药-Diane35。材料和方法。该研究纳入了24名平均年龄为23.2岁的被诊断患有SOP的患者。将患者分为2组:A组,由12名妇女组成(50%),使用Diane 35; B组,12名患者,占50%,使用Diphereline 3,75。结果。注射用地菲林3,75的注射可改善临床症状(痤疮,多毛症,闭经,卵巢形态)。研究结果表明,制备的Diane 35对雄激素性质(尤其是痤疮)的症状具有治疗效果。结论。经临床,激素和形态学数据证明,在诊断为SOP的患者中使用制备的Diphereline 3,75是最有效的治疗变异。另外,该公式允许长时间保持所获得的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号